Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04881513
Other study ID # CHORDA_TASTE_OTOSCLEROSIS
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date January 1, 2022

Study information

Verified date September 2021
Source University Medical Centre Ljubljana
Contact Nina Božanic Urbancic, MD
Phone +38615224183
Email nina.bozanic@kclj.si
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients admitted for the otosclerosis operation are included in the study. The Narrow Band Imaging (NBI) of their taste buds is performed before the operation. The sensory function of the anterior 2/3 of the tongue is tested with the two point discrimination discs, the taste is tested with taste strips and the SF-36 questionnaire is applied. During the operation in local anesthesia the threshold for the tongue sensation (by the stimulation of the chorda tympani nerve) of the first 2/3 of the tongue at the beginning of the operation (when we first encounter the chorda tympani nerve) and at the end of the operation is measured.One month and six months after the operation the tests are being repeated (NBI, two-point discrimination and SF-36 questionnaire). The study has the National Ethical Committee approval.


Description:

Patients admitted for otosclerosis operation 18 to 65 years old, not taking medications that could influence the taste and not having the problems with the smell are being recruited for the study. The informed consent is signed by the patient. The Narrow Band Imaging (NBI) of their taste buds is performed before the operation. The number of taste buds in the 20mm2 size area and the blood vessel morphology is being recorded. For the blood vessel morphology the five point scoring system is used. Both sides of the tongue are tested separately. The sensory function of the anterior 2/3 of the tongue is tested with the two point discrimination discs. Both sides of the tongue are tested separately. The taste strips are used with 4 different concentrations of sweet, sour, salty and bitter applied to each side of the tongue separately. SF-36 questionnaire adapted to Slovenian language is applied. During the operation in local anesthesia the threshold for the tongue sensation at the beginning of the operation (when the investigators first encounter the chorda tympani nerve) and at the end of the operation is measured. The investigators use the facial nerve monitoring system for the measurements and stimulate directly the chorda tympani with electrical current. After each operation the surgeon determines the grade of the intraoperative manipulation of the chorda tympani nerve. One month and six months after the operation the tests are being repeated (NBI, two-point discrimination, taste testing with taste strips and SF-36 questionnaire). The study has the National Ethical Committee approval.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date January 1, 2022
Est. primary completion date December 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: otosclerosis surgery - Exclusion Criteria: smell disturbance, taking drugs that could have the influence on taste, diseases and injuries of the tongue -

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Narrow Band Imaging
Testing the taste buds structure (blood vessels morphology- classified to 5 types) and the number of taste buds per 20mm2, by Narrow Band Imaging technique before and after the operation (one and six months)
Tongue sensitivity testing
testing the tongue sensitivity change prior to surgery and after (1 and 6 months) the surgery with two point discrimination test in mm.
Other:
Qualitiy of life
Testing the patients quality of life before and after (one and six months) the stapes surgery by SF 36 questionnaire
Diagnostic Test:
Threshold change
Measuring the intraoperative chorda tympani stimulation threshold change at the beginning and at the end of the procedure- surgery
Taste
Taste is measured by applying taste strips (sweet, sour, salty, bitter) in 4 concentrations prior to, 1 and 6 months after surgery.

Locations

Country Name City State
Slovenia UMC Ljubljana Ljubljana

Sponsors (1)

Lead Sponsor Collaborator
University Medical Centre Ljubljana

Country where clinical trial is conducted

Slovenia, 

Outcome

Type Measure Description Time frame Safety issue
Primary The change of the count of the taste buds after stapes surgery mesured by NBI The evaluation of the influence of the manipulation of the chorda tympani nerve on the structure of the taste buds measured by Narrow Band Imaging technique prior to surgery and 1 month and 6 months after surgery. The number of the taste buds will be counted on the surface of 20 mm2 . 2 years
Primary The change of the structure -blood vessel morphology of the taste buds after stapes surgery mesured by NBI The evaluation of the influence of the manipulation of the chorda tympani nerve on the structure of the taste buds measured by Narrow Band Imaging technique prior to surgery and 1 month and 6 months after surgery. The blood vessel morphology will be assessed by the 5-point scoring system. 2 years
Primary The change of the function of the taste buds mesured by the test strips The evaluation of the influence of the chorda tympani intraoperative manipulation to the change of the chorda tympani function measured by the taste strips test. 2 years
Primary The influence of the chorda tympani intraoperative manipulation on the patients quality of life The patients quality of life is measured by the SF 36 questionnaire 2 years
Primary The change of the function of the chorda tympani nerve measured by the change of tongue sensitivity measured by two point discrimination test The evaluation of the influence of the chorda tympani intraoperative manipulation to the change of the chorda tympani function measured by the two pint dicrimination test ( in mm) 2 years
See also
  Status Clinical Trial Phase
Completed NCT04532632 - Taste and Smell Impairment in Critically Ill COVID-19 Patients
Completed NCT04145453 - Vegetables Intake and Polymorphism TAS2R38 Gene by Healthy Adults N/A
Recruiting NCT02931812 - Feeding Behavior and Taste Sensitivity Before and After Liver or Renal Transplantation
Not yet recruiting NCT04661800 - Study of Olfactory Disorders in Patients With Cardiac Amyloidosis N/A
Completed NCT04302792 - New Food Solutions for Cancer Patients N/A
Withdrawn NCT05760079 - Lactoferrin for COVID-19-Induced Taste or Smell Abnormality N/A
Completed NCT03196440 - Sensitivity of Basic Taste in Elderly
Completed NCT04235153 - CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients
Recruiting NCT02304913 - Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy N/A
Completed NCT04543175 - Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.
Completed NCT04923321 - Taste Supra-thresholds Among a Sample of Depressed Egyptian Adult Under Anti-depressants Therapy
Completed NCT03599011 - Gustatory Dysfunction Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy
Completed NCT04923425 - Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy
Completed NCT03498950 - Changes in Sense of Taste of Patients Submitted to Hematopoietic Stem Cell Transplantation N/A
Withdrawn NCT03043144 - Taste And Smell TEsting in End Stage Renal Disease N/A
Not yet recruiting NCT05104424 - The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions Phase 1
Completed NCT01540045 - Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Completed NCT05227157 - GOUTMETALSAIN: Comparison of the Perception of Metallic Taste According to Lingual Locations in Healthy Volunteers
Completed NCT00316563 - Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study Phase 2